Derivation Web

source_3b4a0e0a9df14eb2

**Selected angle:** `source`

## One-sentence thesis

The cited direct receipts support a bounded working claim: 55.8% vs 13.2%, respectively; P < .001; Gastrointestinal events were reported in 49.1% of participants who continued subcutaneous semaglutide vs 26.1% with placebo.


**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-deri…